Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 04 2020
revised: 24 04 2020
accepted: 26 04 2020
pubmed: 4 5 2020
medline: 29 7 2020
entrez: 4 5 2020
Statut: ppublish

Résumé

The first cases of COVID-19 infection were reported in December, 2019, in Wuhan, China. Italy (in particular Lombardy) and France (in particular Northeast) have been gravely hit. Both physicians and inflammatory bowel disease (IBD) patients are deeply concerned that immunosuppressants or biologics may increase the risk of COVID-19 infection. IOIBD has put in place an international registry, SECURE-IBD, for tracking all the cases with IBDs infected by COVID-19 (SECURE-IBD registry: http://www.covidibd.org). It will describe the outcomes of infected patients and the association between IBD-related medications and these outcomes.

Identifiants

pubmed: 32360811
pii: S1542-3565(20)30616-9
doi: 10.1016/j.cgh.2020.04.071
pmc: PMC7191273
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2134-2135

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

Gastroenterology. 2018 Aug;155(2):337-346.e10
pubmed: 29655835
Lancet Infect Dis. 2018 Aug;18(8):e217-e227
pubmed: 29680581
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846

Auteurs

Mariangela Allocca (M)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy. Electronic address: mariangela.allocca@humanitas.it.

Gionata Fiorino (G)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.

Camille Zallot (C)

Department of Gastroenterology, Inserm U1256 Nutrition - génétique et exposition aux risques environnementaux, Nancy University Hospital, Lorraine University, Vandoeuvre-les-Nancy, France.

Federica Furfaro (F)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.

Daniela Gilardi (D)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.

Simona Radice (S)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.

Silvio Danese (S)

Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology, Inserm U1256 Nutrition - génétique et exposition aux risques environnementaux, Nancy University Hospital, Lorraine University, Vandoeuvre-les-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH